SERIAL ASSESSMENT OF CARDIAC BIOMARKERS IN ACUTE MYOCARDIAL INFARCTION: A COMPREHENSIVE STUDY

Authors

  • HARSHAL PACHPOR Department of Biochemistry, Government Medical College and SSH Nagpur, Maharashtra, India
  • ARUN TADAS Department of Biochemistry, Indira Gandhi Government Medical College, Nagpur, Maharashtra, India.
  • SANDIP LAMBE Department of Biochemistry, SMBT Institute of Medical Science and Research Center, Nashik, Maharashtra, India.
  • AVINASH NAMDEO JADHAO Department of Biochemistry, Seth Gordhandas Sunderdas Medical College and KEMH Parel Mumbai, Maharashtra, India

DOI:

https://doi.org/10.22159/ajpcr.2025v18i2.53542

Keywords:

Acute myocardial infarction, Cardiac troponin T creatine kinase MB isoenzyme, Aspartate aminotransferase transaminase, Lactate dehydrogenase.Lactate dehydrogenase.

Abstract

Objectives: To examine the correlation between the serial activity of cardiac troponin T (cTnT) and the enzymatic activities of creatine kinase MB (CPK-MB), lactate dehydrogenase (LDH), and aspartate aminotransferase (AST) in patients with acute myocardial infarction (AMI).

Methods: This hospital-based retrospective observational study involved 50 patients diagnosed with AMI, including those with non-segment elevation myocardial infarction, and 50 healthy age- and sex-matched controls. All participants underwent electrocardiographic evaluation and serial blood sample collection at 6, 24, and 48 h post-admission. cTnT levels were measured using electro-chemiluminescence immunoassay, while CPK-MB levels were assessed by immunoinhibition methodology. Serum levels of LDH and AST were determined using the UV kinetic method on a fully automated autoanalyzer.

Results: At 6, 24, and 48 h, cardiac biomarkers were significantly elevated in patients with AMI compared to healthy controls. cTnT levels were 1.13±1.24 ng/mL at 6 h, 3.64±0.34 ng/mL at 24 h, and 5.84±0.39 ng/mL at 48 h, while the control group showed a value of 0.09±0.18 ng/mL. Similarly, serum CPK-MB levels were 99.68±31.46 ng/mL at 6 h, 186.42±54.20 ng/mL at 24 h, and 124.28±46.53 ng/mL at 48 h. Serum AST (serum glutamic-oxaloacetic transaminase) levels were 78.34±26.25 IU/L at 6 h, 173.90±56.03 IU/L at 24 h, and 119.31±36.21 IU/L at 48 h. Finally, serum LDH levels progressively increased, reaching 521.53±118.36 IU/L at 6 h, 1025.36±101.85 IU/L at 24 h, and 1823.21±129.34 IU/L at 48 h. These findings demonstrate a time-dependent rise in biomarker levels following myocardial injury.

Conclusion: The biomarkers troponin T, CPK-MB, LDH, and AST provide valuable insights into the extent and severity of myocardial injury in patients with AMI. Monitoring their levels over time can aid in the diagnosis, risk stratification, and management of patients with AMI.

Downloads

Download data is not yet available.

References

Zimmerman J, Fromm R, Meyer D, Boudreaux A, Wun CC, Smalling R, et al. Diagnostic marker cooperative study for the diagnosis of myocardial infarction. Circulation. 1999;99(13):1671-7. doi: 10.1161/01.cir.99.13.1671, PMID: 10190875

Nigam PK. Biochemical markers of myocardial injury. Indian J Clin Biochem. 2007;22(1):10-7. doi: 10.1007/BF02912874, PMID: 23105645

Roberts R, Henry PD, Witteeveen SA, Sobel BE. Quantification of serum creatine phosphokinase isoenzyme activity. Am J Cardiol. 1974;33(5):650-4. doi: 10.1016/0002-9149(74)90257-4, PMID: 4150703

Hajar R. Evolution of myocardial infarction and its biomarkers: A historical perspective. Heart Views. 2016;17(4):167-72. doi: 10.4103/1995-705X.201786, PMID: 28400945

Rashid S, Malik A, Khurshid R, Faryal U, Qazi S. The diagnostic value of biochemical cardiac markers in acute myocardial infarction. In: Pamukçu B, editor. Myocardial Infarction. London: IntechOpen; 2019. doi: 10.5772/intechopen.76150

Xu RY, Zhu XF, Yang Y, Ye P. High-sensitive cardiac troponin T. J Geriatr Cardiol. 2013;10(1):102-9. doi: 10.3969/j.issn.1671- 5411.2013.01.015, PMID: 23610580

Daubert MA, Jeremias A. The utility of troponin measurement to detect myocardial infarction: Review of the current findings. Vasc Health Risk Manag. 2010;6:691-9. doi: 10.2147/vhrm.s5306, PMID: 20859540

Sobel BE, Shell WE. Serum enzyme determinations in the diagnosis and assessment of myocardial infarction. Circulation. 1972;45(2):471- 82. doi: 10.1161/01.cir.45.2.471, PMID: 5009490

Katus HA, Remppis A, Neumann FJ, Scheffold T, Diederich KW, Vinar G, et al. Diagnostic efficiency of troponin T measurements in acute myocardial infarction. Circulation. 1991;83(3):902-12. doi: 10.1161/01.cir.83.3.902, PMID: 1999039

Adams JE 3rd, Abendschein DR, Jaffe AS. Biochemical markers of myocardial injury. Is MB creatine kinase the choice for the 1990s? Circulation. 1993;88(2):750-63. doi: 10.1161/01.cir.88.2.750, PMID: 8339435

Singh A, Uthappa S, Govindaraju V, Venkatesh T. Serum markers for early diagnosis of non-‘Q’ wave and ‘Q’ wave myocardial infarction. Indian J Clin Biochem. 2002;17(1):25-8. doi: 10.1007/BF02867937, PMID: 23105332

Karmen A, Wroblewski F, Ladue JS. Transaminase activity in human blood. J Clin Invest. 1955;34(1):126-31. doi: 10.1172/JCI103055, PMID: 13221663

Published

07-02-2025

How to Cite

HARSHAL PACHPOR, ARUN TADAS, SANDIP LAMBE, and AVINASH NAMDEO JADHAO. “SERIAL ASSESSMENT OF CARDIAC BIOMARKERS IN ACUTE MYOCARDIAL INFARCTION: A COMPREHENSIVE STUDY”. Asian Journal of Pharmaceutical and Clinical Research, vol. 18, no. 2, Feb. 2025, pp. 34-37, doi:10.22159/ajpcr.2025v18i2.53542.

Issue

Section

Original Article(s)